These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6119243)

  • 1. Reactive protein and immunoglobulin levels in women using intrauterine devices.
    Shaarawy M; Naguib YA; El Safory LS; Abdel Kader MM
    Int J Gynaecol Obstet; 1981 Apr; 19(2):125-31. PubMed ID: 6119243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno and histochemical study of endometrium in women using copper IUCD.
    Mousa MA; El-mekkawi TM; Abdel Aziz AA; El-saharty MF
    Popul Sci; 1985; 6():41-50. PubMed ID: 12349093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structural and morphofunctional changes in the endometrium after postpartum insertion of the intrauterine device].
    Zheleznov BI; Orlova VS; Khopina AA
    Akush Ginekol (Mosk); 1982 Oct; (10):26-30. PubMed ID: 7180994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper levels in women using intrauterine devices or oral contraceptives.
    Hefnawi F; Kandil O; Askalani H; Zaki K; Nasr F; Mousa M
    Fertil Steril; 1974 Jul; 25(7):556-61. PubMed ID: 4841618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs.
    Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A
    Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cervical mucus copper and zinc in women using I.U.D.s.
    Tagi AH; Awad AH; El Hemaly AK; Ibrahim H; El Masry GI; Morad M
    Popul Sci; 1985; 6():35-40. PubMed ID: 12349092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial reaction to intrauterine device in pregnancy.
    Ezra Y; Birkenfeld A; Levij IS
    Gynecol Obstet Invest; 1989; 28(1):5-7. PubMed ID: 2777135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the intrauterine contraceptive device on protein components of human uterine fluid.
    Tauber PF; Cramer GM; Zaneveld LJ
    Contraception; 1993 Nov; 48(5):494-512. PubMed ID: 8275697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
    Faundes A; Alvarez F; Brache V; Tejada AS
    Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the acceptability of inert and copper-containing intrauterine contraceptive devices].
    Manuilova IA; Dubnitskaia LV
    Akush Ginekol (Mosk); 1988 Nov; (11):47-50. PubMed ID: 3239684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of intrauterine devices.
    Ortiz ME; Croxatto HB; Bardin CW
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S42-51. PubMed ID: 8972502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of immunoglobulins and complement components in women using an intra-uterine contraceptive device (IUCD).
    Sandvei R; Matre R
    Acta Obstet Gynecol Scand; 1987; 66(4):297-9. PubMed ID: 3425227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial reaction with long use of intrauterine contraceptive devices (7-9 years).
    Hefnawi F; Askalani AH; Hasseeb F; Issa A
    Egypt Popul Fam Plann Rev; 1974 Jun; 7(1):1-10. PubMed ID: 12257563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.